Connect your AI

Nurix Therapeutics, Inc. NRIX Earnings yield

Earnings yield at other companies

Kymera TherapeuticsKYMR

-4.6%-1.8pp

Monte Rosa Therapeutics, Inc.GLUE

-9.9%—

Stoke Therapeutics, Inc.STOK

-8.8%-22.8pp

Viridian Therapeutics, Inc.VRDN

-18%-4.7pp

Nuvation BioNUVB

-9.8%-4.6pp

Ultragenyx PharmaceuticalRARE

-29.6%+144pp

Other financials

Income statement

Revenue$6.3M-66.1%

Operating income-$92.5M-47.1%

Net income-$87.2M-54.7%

EPS (diluted)-$0.79-17.9%

Balance sheet

Cash & equivalents$72.2M-6.1%

Total debt$58.7M+120%

Total equity$480.9M0.0%

Total assets$636.1M+3.4%

Cash flow

Operating cash flow-$71.9M-17.7%

CapEx$1.0M-70.0%

Free cash flow-$73.0M-13.0%

Valuation

Market cap$1.95B+40.1%

Enterprise value$1.94B+45.1%

P/S27.2×+2.5×

Profitability

Operating margin-439.3%+35.3pp

Net margin-411.4%+52.7pp

FCF margin-378.7%+24.1pp

Returns & leverage

Return on equity-61.4%-2.5pp

Debt / equity0.1×+0.1×

Current ratio6×-0.3×

Where this comes from

Calculated from Nurix Therapeutics, Inc.’s reported figures.

net income/market cap=-18%

Based on trailing twelve months.

The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nurix Therapeutics, Inc.'s earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Nurix Therapeutics, Inc.'s earnings yield?: Nurix Therapeutics, Inc. (NRIX) reported earnings yield of -18% in Q4 2025.
How has Nurix Therapeutics, Inc.'s earnings yield changed year-over-year?: Nurix Therapeutics, Inc.'s earnings yield decreased by 1.1% year-over-year, from -17.8% to -18%.
What is the long-term trend for Nurix Therapeutics, Inc.'s earnings yield?: Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s earnings yield has grown at a 41.3% compound annual growth rate (CAGR), from -2.6% to -14.8%.
What does earnings yield mean?: Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.